Keith Boettiger, VP of Abbott’s heart failure business, posted the update on LinkedIn. He said CMS granted a new national coverage determination for CardioMEMS.

“This decision is a massive step forward toward increasing access to CardioMEMS to millions of heart failure patients,” Boettiger said.

Remote monitoring technologies like the Abbott CardioMEMS sensor enable better management of heart failure. The CardioMEMS sensor’s design enables it to help people and their physicians proactively manage heart failure. It also helps to potentially prevent events that could lead to hospitalization.